Better Health, Brighter Future
Launch of Takeda Corporate YouTube Channel
Osaka, Japan, November 29, 2019 --- Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) today announced the official launch of the Takeda Corporate YouTube Channel (www.youtube.com/takeda-pharmaceuticals/).
The new YouTube channel launched to increase awareness and understanding on our mission to bring better health and a brighter future to people worldwide through video storytelling. The channel shares engaging and emotional stories, alongside educational and healthcare related topics. Initial playlists highlight our corporate philosophy; as well as our R&D approach to translate science into life changing medicines, global health, manufacturing, disease awareness and various other global activities. The channel will be updated periodically with new playlists and video content including region specific information.
To stay up to date on our latest activities and for insights into healthcare innovation, please subscribe to Takeda Corporate YouTube Channel.
The new YouTube channel launched to increase awareness and understanding on our mission to bring better health and a brighter future to people worldwide through video storytelling. The channel shares engaging and emotional stories, alongside educational and healthcare related topics. Initial playlists highlight our corporate philosophy; as well as our R&D approach to translate science into life changing medicines, global health, manufacturing, disease awareness and various other global activities. The channel will be updated periodically with new playlists and video content including region specific information.
To stay up to date on our latest activities and for insights into healthcare innovation, please subscribe to Takeda Corporate YouTube Channel.
Takeda Corporate YouTube Channel Home
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.
For more information, visit https://www.takeda.com.